Meeting Coverage
ESC
European Society of Cardiology Congress
But is it worthwhile without a mortality benefit? Trials present complex picture
Latest ESC Meetings
Good signals in people with large acute MIs at risk of developing heart failure
Meta-analysis challenges central role of aspirin, researcher says
A meta-analysis pointed to a low incidence of drug-related pain
Preventing ischemic events is a less clear benefit
Approach beats coronary access through the thigh
Modality helps avoid unnecessary intervention in heart attack patients with multivessel disease
Meta-analysis settles the confusion around angiotensin receptor blockers
Head-to-head trial finds "interchangeable" accuracy
South Korean trial showed no improvement in clinical outcomes at 2 years
Danish pilot study lays groundwork for larger trial looking for better CV outcomes
Inappropriate shocks among early challenges of device therapy under the sternum
Ischemic event prevention didn't pan out in INVICTUS trial
SGLT2 inhibitor shines in landmark DELIVER trial
Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says